Skip to content

Microbot Medical MBOT Income Tax Reconciliation Foreign Income Tax Rate Differential

Income Tax Reconciliation Foreign Income Tax Rate Differential at other companies

RFL
Rafael Holdings, Inc.RFL
-$8.5K-3,300%

Other financials

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×

Profitability

See full
Operating margin25,292.9%
Net margin-3,669.9%
FCF margin-852.8%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's income tax reconciliation foreign income tax rate differential.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's income tax reconciliation foreign income tax rate differential?
Microbot Medical (MBOT) reported income tax reconciliation foreign income tax rate differential of -$32.5K in Q4 2025.
What does income tax reconciliation foreign income tax rate differential mean?
Measures the impact on the total tax provision resulting from the difference between the domestic statutory tax rate and the tax rates applicable to foreign jurisdictions where the company operates. This highlights the tax benefit or burden associated with the company's international footprint.